Set to Pocket $5M in Financing, InforSense Shuffles Execs | GenomeWeb

NEW YORK (GenomeWeb News) — Software company InforSense said today that it has received a $5 million financing commitment from existing investors, and that company founder Yike Guo will be stepping down from the CEO position to serve as chief technology officer and head of innovation.

David Bennett, who joined the company in January 2008 as executive vice president of worldwide sales, has been appointed the company's new CEO, effective immediately.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.